Sigma-Aldrich — Merger or Acquisition (October 2014)
40 slides from Sigma-Aldrich's merger presentation, Oct 2, 2014
Slide 1: Living Innovation since 1668
M Merck KGaA Darmstadt Germany LIVING INNOVATION SINCE 1668 M
Slide 2: Disclaimer: Cautionary Note Regarding Forward-Looking Statements
M Merck KGaA Darmstadt Germany Disclaimer Cautionary Note Regarding Forward-Looking Statements This communication may include “forward-looking statements.” Statements that include words such as “anticipate,” “expect,” “should,” “would,” “intend,” “plan,” “project,” “seek,” “believe,” “will,” and oth
Slide 3: What we aim for: Our mission
M Merck KGaA Darmstadt Germany What we aim for: Our mission Our aspiration is to make great things happen. With our research-driven specialty businesses, we help patients, customers, partners and our communities around the world to live a better life. We deliver entrepreneurial success through innov
Slide 4: What guides us: Our values
M Merck KGaA Darmstadt Germany What guides us: Our values Everything we do is based on our six company values. Courage opens the door to the future, Achievement makes our entrepreneurial success possible, Responsibility determines our entrepreneurial actions, Respect is the foundation of any partner
Slide 5: Founded in 1668: key facts
M Merck KGaA Darmstadt Germany Founded in 1668 66 countries Business fields: Pharmaceuticals, life sciences, performance materials over 38,000 employees €1.5 billion invested in R&D in 2013 €11.1 billion total revenues in 2013
Slide 6: We are Merck – the original
M Merck KGaA Darmstadt Germany EMD MERCK We are Merck – the original In 1887, Merck opened its own office in New York, which gave rise to the subsidiary Merck & Co. three years later. As a result of World War I, this subsidiary was expropriated in 1917 and has been an independent company ever since
Slide 7: A strong financial basis
M Merck KGaA Darmstadt Germany A strong financial basis Sales in € billion 7.4 8.9 9.9 10.7 10.7 2009 2010 2011 2012 2013 EBITDA pre one-time items in € billion 1.7 2.5 2.7 3.0 3.3 2009 2010 2011 2012 2013 Sales in € billion by business 25% Merck Millipore 2.63 53% Merck Serono 5.69 15% Performance
Slide 8: We are global
M Merck KGaA Darmstadt Germany We are global We operate around the world and have a strong presence in the emerging markets. In 2013, we generated 36% of our sales in these global growth markets - a share that is likely to increase further. 114 nationalities are represented at Merck and our employee
Slide 9: Well positioned across our businesses
M Merck KGaA Darmstadt Germany Well positioned across our businesses Pharmaceuticals Global leader in fertility medicine World’s largest supplier of drugs to treat thyroid disorders Global leader in probiotic vitamins (Bion®) Global leader in B vitamins (Neurobion®) European leader in pregnancy vita
Slide 10: Global research
M Merck KGaA Darmstadt Germany Global research In 2013, we invested nearly € 1.2 billion in R&D at Merck Serono in order to develop even better treatment options. More than 2,300 experts work at our research hubs in Darmstadt, Boston, Beijing and Tokyo, and we maintain close partnerships with biotec
Slide 11: Million Merck babies
M Merck KGaA Darmstadt Germany 2 million Merck babies Many couples need help in making their dream of becoming parents come true. Merck is a global leader in fertility medicine. An estimated 2 million babies have been born thanks to products we offer, such as Gonal-f®.
Slide 12: High-Tech pharma production
M Merck KGaA Darmstadt Germany High-Tech pharma production Our biotech center in Vevey, Switzerland is one the largest and most modern biotech facilities in the world. Here, we produce biotech products for clinical research and commercialization. This includes the active ingredient in our multiple s
Slide 13: Nasivin on the moon
M Merck KGaA Darmstadt Germany Nasivin on the moon Weightlessness in outer space causes the nasal mucous membranes to swell – something that is just as unpleasant for astronauts as it is for cold sufferers on Earth. NASA therefore started equipping the medical kits of its space missions with oxymeta
Slide 14: We make future visible
M Merck KGaA Darmstadt Germany We make future visible From touch screens to 3D televisions: We have played a part in all key display innovations. And we are continuing our research. For example, we are developing flexible screens, holographic displays and 3D viewing experiences without the need for
Slide 15: You can eat our pigments
M Merck KGaA Darmstadt Germany You can eat our pigments Our pigments are used to great effect in the food and beverage industry. For example, our Candurin® pigments give a special silver shine to Magnum’s anniversary edition “Magnum Silver 25”.
Slide 16: Muse – Our inspiration for your research
M Merck KGaA Darmstadt Germany Muse® – Our inspiration for your research The Muse® cell analyzer provides real-time data on important cell health parameters. There is no longer any need for time-consuming individual measurements of parameters such as cell count and viability, apoptosis and cell cycl
Slide 17: Keeping things clean
M Merck KGaA Darmstadt Germany Keeping things clean Safety and purity have top priority in pharmaceutical manufacture, which is why our products meet the highest quality standards. And we ensure that this applies to the final product as well. With our Milliflex® system, microbial contamination can b
Slide 18: Making sure food is safe
M Merck KGaA Darmstadt Germany Making sure food is safe Our analysis products are used by food manufacturers in order to continuously monitor the quality of their goods. For example, our high-purity reagents and chromatography systems support compliance with the very stringent international food reg
Slide 19: Our recipe for success: the ability to change
M Merck KGaA Darmstadt Germany OUR RECIPE FOR SUCCESS THE ABILITY TO CHANGE M
Slide 20: 1668 – A new horizon
M Merck KGaA Darmstadt Germany 1668 – A new horizon In 1668, Friedrich Jacob Merck purchased the Engel-Apotheke (Angel Pharmacy) in Darmstadt, which would become the historic core of the company. This makes Merck the world’s oldest pharmaceutical and chemical company. The Angel Pharmacy exists to th
Slide 21: From pharmacy to global company
M Merck KGaA Darmstadt Germany From pharmacy to global company In 1816, Emanuel Merck took over the “Engel Apotheke” and initiated the transformation from a manual pharmacy craftsmanship to a research-based industrial company. He started the industrial-scale manufacture of his products, offered a co
Slide 22: 2007: Acquisition of Serono
M Merck KGaA Darmstadt Germany 2007: Acquisition of Serono Merck Serono is the biopharmaceutical division of Merck. The acquisition of Serono in 2007 expanded our portfolio of prescription medicines. Today, we use our knowledge and experience to develop specialist therapies to treat cancer, multiple
Slide 23: 2010: Acquisition of Millipore
M Merck KGaA Darmstadt Germany 2010: Acquisition of Millipore Through the acquisition of Millipore, we have become a global leader in the life science sector. With more than 60,000 products for the life science industry, we offer solutions to make scientific research and biotech manufacturing easier
Slide 24: 2014: Acquisition of AZ Electronic Materials
M Merck KGaA Darmstadt Germany 2014: Acquisition of AZ Electronic Materials AZ is a leading provider of high-tech materials for the electronics industry. With the integration of this business, we are complementing our display expertise and are able to offer our customers more comprehensive and compl
Slide 25: Our recipe for success: the ability to innovate
M Merck KGaA Darmstadt Germany OUR RECIPE FOR SUCCESS THE ABILITY TO INNOVATE M
Slide 26: Carrots in the television – our LC story
M Merck KGaA Darmstadt Germany Carrots in the television - our LC story Liquid crystals were discovered by chance in 1888 - in carrots. Shortly afterwards, Merck embarked on research and produced high-purity liquid crystals. Yet their technological application in LC displays came only in the 1960s.
Slide 27: Organic high-tech
M Merck KGaA Darmstadt Germany Organic high-tech We are researching the next generation of materials for lighting and displays - organic light-emitting diodes (OLEDs). Not only are they extremely energy-efficient, they also provide brilliant colors and sharp images from every viewing angle - which m
Slide 28: Anchoring innovation at the heart of Merck
M Merck KGaA Darmstadt Germany Anchoring innovation at the heart of Merck In time for our 350-year anniversary, we are re-modeling our corporate headquarter in Darmstadt. At the heart of this will be an innovation center to ensure that Merck remains the innovative company that it is.
Slide 29: Our recipe for success: responsible entrepreneurship
M Merck KGaA Darmstadt Germany OUR RECIPE FOR SUCCESS RESPONSIBLE ENTREPRENEURSHIP M
Slide 30: We unite the best of two worlds
M Merck KGaA Darmstadt Germany We unite the best of two worlds Merck KGaA Total capital 100% Merck Family Equity interest 70.3% Family-owned for 12 generations Shareholders Share capital 29.7% Publicly traded since 1995 DAX member since 2007 30 Living Innovation since 1668 | 24 July 2014
Slide 31: We've got something against worms
M Merck KGaA Darmstadt Germany We’ve got something against worms More than 200 million people in Africa suffer from the tropical disease schistosomiasis, resulting in 200,000 deaths a year. In children, the parasitic worm disease stunts growth and reduces their ability to learn. Together with the WH
Slide 32: Minilabs – Fighting counterfeit drugs
M Merck KGaA Darmstadt Germany Minilabs - Fighting counterfeit drugs Millions of people depend on crucial medications, but - unknown to them - end up taking a pill made of nothing more than flour, sugar or sawdust. This happens because up to 30% of medicines sold worldwide are counterfeit. However,
Slide 33: Committed to clean water
M Merck KGaA Darmstadt Germany Committed to clean water When it comes to fast and precise analysis, we have been a leading specialist for more than 100 years. From A for Arsenic to Z for Zinc, our devices and test kits analyze the substances in water with the utmost precision. After all, we want peo
Slide 34: 20% less by 2020
M Merck KGaA Darmstadt Germany 20% less by 2020 Climate protection concerns each and every one of us. We have therefore set ourselves the goal of reducing our greenhouse gas emissions by 20% by 2020, relative to the 2006 baseline. We do so by making our processes more efficient and conserving energy
Slide 35: Smart Windows – the green solution
M Merck KGaA Darmstadt Germany Smart Windows - the green solution Liquid crystals are not only highly suitable for use in displays. We are developing smart windows which, thanks to liquid crystals, can regulate the amount of sunlight entering a building. They ensure that the building stays pleasantl
Slide 36: We're setting the tone
M Merck KGaA Darmstadt Germany We’re setting the tone The Deutsche Philharmonie Merck consists of 80 professional musicians. It features a wide-ranging concert program involving numerous international performances and attracts more than 20,000 music lovers per year. Tickets are available at www.phil
Slide 37: Our ambitions for 2018
M Merck KGaA Darmstadt Germany Our ambitions for 2018 For our 350th anniversary, we want to be known for innovation, quality, as well as performance and efficiency. We want to be liked for customer orientation, our entrepreneurial spirit, and for the career opportunities that we offer. And we want t
Slide 38: In a nutshell
M Merck KGaA Darmstadt Germany IN A NUTSHELL M 38 Living Innovation since 1668 | 24 July 2014
Slide 39: Merck – Living Innovation since 1668
M Merck KGaA Darmstadt Germany Merck - Living Innovation since 1668 The best of two worlds: Family ownership & Publicly traded A successful mix: & Maintaining our traditions Being able to change A sustainable strategy: Dynamic and innovative & entrepreneurship Corporate responsibility 39 Living Inno
Slide 40: Contact Merck
M Merck KGaA Darmstadt Germany CONTACT MERCK Frankfurter Strasse 250 64293 Darmstadt, Germany www.merckgroup.com PHONE +49 6151 72-0 FAX +49 6151 72-2000 Status: June 2014, published by Merck, Group Communications